Venture capital firm based in London, UK
MIP Discovery secures £7m investment to revolutionize cell and gene therapy manufacturing with synthetic antibody alternatives, paving the way for widespread adoption of life-changing medicines. Read more
With $3 million in fresh funding, Optalix is set to redefine the finance software landscape, powering innovation and expansion in the insurance, banking, and healthcare sectors! Read more
Arctic Shores secures a game-changing £5.75 million in Series B funding to supercharge their innovative psychometric assessments and conquer the European market! Read more
Laverock Therapeutics secures £13.5M in Seed funding to advance its groundbreaking gene silencing platform and drive advancements in regenerative medicine and immuno-oncology. Read more
Tagomics secures £6.7M in funding to revolutionize disease diagnosis and treatment with its cutting-edge multiomic platform, led by a powerhouse group of investors. Read more
WorkL secures £2M Series A funding with Calculus Capital to accelerate international growth and continue revolutionizing workplace happiness on a global scale. Read more
Notify Technologies secures £1.5 million to enhance its AI-driven SHEQ management system, setting a new standard in workplace safety. Read more
Healthtech | 50.0% |
Biotech | 18.8% |
Energy | 6.3% |
Tech | 6.3% |
AI | 6.3% |
Data | 6.3% |
HRtech | 6.3% |